BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+16.15%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$11.4B
AUM Growth
+$11.4B
(-5.2%)
Cap. Flow
-$1.07B
Cap. Flow
% of AUM
-9.36%
Top 10 Holdings %
Top 10 Hldgs %
75.13%
Holding
140
New
10
Increased
24
Reduced
17
Closed
12
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$1.18B |
| 2 |
AbbVie
ABBV
|
$966M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$96.5M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$50.5M |
| 5 |
ATYR
aTyr Pharma
ATYR
|
$43.2M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
$2.31B |
| 2 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$1.14B |
| 3 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$44.8M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$17M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$14.4M |
Sector Composition
| 1 | Healthcare | 72.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.5B
| $1.55B | 13.59% | 14,865,559 +20,000 | +0.1% | +$2.08M |
|
|
SGEN
2
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.49B | 13.11% | 30,870,262 +1,993,550 | +7% | +$96.5M |
|
|
ALXN
3
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.18B | 10.37% | +6,542,599 | New | +$1.18B |
|
|
4
AbbVie
ABBV
$372B
| $966M | 8.47% | +14,373,538 | New | +$966M |
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $858M | 7.52% | 20,481,442 | – | – |
|
|
6
BioMarin Pharmaceuticals
BMRN
$11.2B
| $560M | 4.91% | 4,095,247 -105,209 | -3% | -$14.4M |
|
|
GHDX
7
DELISTED
Genomic Health, Inc.
GHDX
| $380M | 3.33% | 13,657,598 +656 | +0% | +$18.2K |
|
|
ANAC
8
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $281M | 2.46% | 3,625,498 -579,204 | -14% | -$44.8M |
|
|
DYAX
9
DELISTED
DYAX CORPORATION
DYAX
| $210M | 1.84% | 7,926,630 +1,905,145 | +32% | +$50.5M |
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $173M | 1.52% | 11,577,299 +1,099,095 | +10% | +$16.4M |
|
|
NVTA
11
DELISTED
Invitae Corporation
NVTA
| $97.5M | 0.86% | 6,554,967 | – | – |
|
|
BLCM
12
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $89.1M | 0.78% | 4,190,594 | – | – |
|
|
MRTX
13
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $88.3M | 0.77% | 2,805,074 | – | – |
|
14
Heron Therapeutics
HRTX
$207M
| $87.5M | 0.77% | 2,807,784 +200,000 | +8% | +$6.23M |
|
|
ONCE
15
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $76.1M | 0.67% | 1,262,382 -65,069 | -5% | -$3.92M |
|
16
Cerus
CERS
$251M
| $70.3M | 0.62% | 13,553,275 | – | – |
|
17
Xoma
XOMA
$392M
| $57M | 0.5% | 14,683,513 -25,100 | -0.2% | -$97.4K |
|
|
DBVT
18
DBV Technologies
DBVT
$264M
| $55.5M | 0.49% | 1,862,019 +342,790 | +23% | +$10.2M |
|
|
ARAV
19
DELISTED
Aravive, Inc. Common Stock
ARAV
| $52.3M | 0.46% | 3,436,585 +459,189 | +15% | +$6.99M |
|
|
ALDR
20
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $47.2M | 0.41% | 891,688 +12,107 | +1% | +$641K |
|
21
Halozyme
HALO
$8.56B
| $43.6M | 0.38% | 1,931,057 -317,095 | -14% | -$7.16M |
|
|
ATYR
22
aTyr Pharma
ATYR
$527M
| $43.2M | 0.38% | +2,335,125 | New | +$43.2M |
|
|
XNPT
23
DELISTED
XENOPORT, INC.
XNPT
| $39.9M | 0.35% | 6,508,622 | – | – |
|
|
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
| $39.5M | 0.35% | 5,482,505 -176,250 | -3% | -$1.27M |
|
25
Insmed
INSM
$28.8B
| $38.7M | 0.34% | 1,583,490 | – | – |
|